Candel Therapeutics (CADL) Institutional Ownership → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free CADL Stock Alerts $6.39 -0.04 (-0.62%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Candel Therapeutics (NASDAQ:CADL)CurrentInstitutional OwnershipPercentage13.93%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$34.33KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$29.99K Get CADL Insider Trade Alerts Want to know when executives and insiders are buying or selling Candel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CADL Institutional Buying and Selling by Quarter Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Candel Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/29/2024Baystate Wealth Management LLC76,910$113K0.0%-21.0%0.266% 5/10/2023Resources Investment Advisors LLC.25,428$34K0.0%N/A0.088% 4/25/2023Baystate Wealth Management LLC105,854$143K0.0%N/A0.366% 11/14/2022Point72 Asset Management L.P.403,131$1.27M0.0%-45.7%1.395% 5/6/2022Empirical Asset Management LLC12,000$61K0.1%N/A0.042% 4/26/2022Kestra Advisory Services LLC12,500$64K0.0%N/A0.044% 2/15/2022Northpond Ventures LLC1,935,215$15.13M5.3%N/A6.745% 2/15/2022683 Capital Management LLC40,929$320K0.0%N/A0.143% 11/15/2021Caas Capital Management LP50,000$542K0.0%N/A0.174% 11/15/2021Franklin Resources Inc.1,125,000$12.20M0.0%N/A3.921% 11/9/2021BlackRock Inc.22,326$242K0.0%N/A0.078% (Data available from 1/1/2016 forward) CADL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CADL shares? During the previous two years, the following institutional investors and hedge funds held shares of Candel Therapeutics shares: Point72 Asset Management L.P. ($1.27M), Baystate Wealth Management LLC ($113K), and Empirical Asset Management LLC ($61K), Resources Investment Advisors LLC. ($34K).Learn more on CADL's institutional investors. What percentage of Candel Therapeutics stock is owned by institutional investors? 13.93% of Candel Therapeutics stock is owned by institutional investors. Learn more on CADL's institutional investor holdings. Which institutional investors have been buying Candel Therapeutics stock? The following institutional investors have purchased Candel Therapeutics stock in the last 24 months: Baystate Wealth Management LLC ($105.85K), Resources Investment Advisors LLC. ($25.43K), and Empirical Asset Management LLC ($12K). How much institutional buying is happening at Candel Therapeutics? Institutional investors have bought a total of 143,282 shares in the last 24 months. This purchase volume represents approximately $238.31K in transactions. Which Candel Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Candel Therapeutics stock in the last 24 months: Point72 Asset Management L.P. ($339.95K), and Baystate Wealth Management LLC ($20.40K). How much institutional selling is happening at Candel Therapeutics? Institutional investors have sold a total of 360,351 shares in the last 24 months. This volume of shares sold represents approximately $1.10M in transactions. Related Companies: CGEN Institutional Ownership VCXB Institutional Ownership INMB Institutional Ownership GNFT Institutional Ownership GRPH Institutional Ownership VXRT Institutional Ownership PSTX Institutional Ownership IPSC Institutional Ownership MOLN Institutional Ownership KOD Institutional Ownership This page (NASDAQ:CADL) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Candel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
